Thierry Calandra

Research interests

Publications

• Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion

  Intensive Care Medicine · 2020 · https://doi.org/10.1007/s00134-020-06091-6

• Risk factors for candidemia: a prospective matched case-control study

  Critical Care · 2020 · https://doi.org/10.1186/s13054-020-2766-1

• Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

  Clinical Infectious Diseases · 2019 · https://doi.org/10.1093/cid/ciz1008

• Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines

  Journal of Infection · 2017 · https://doi.org/10.1016/j.jinf.2017.10.009

• Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines

  Journal of Infection · 2017 · https://doi.org/10.1016/j.jinf.2017.10.009

• Changes in the epidemiological landscape of invasive candidiasis

  Journal of Antimicrobial Chemotherapy · 2017 · 10.1093/jac/dkx444

• ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients

  Haematologica · 2016 · https://doi.org/10.3324/haematol.2016.152900

• Sepsis: a roadmap for future research

  The Lancet Infectious Diseases · 2015 · https://doi.org/10.1016/s1473-3099(15)70112-x

• ESCMID guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases

  Clinical Microbiology and Infection · 2012 · https://doi.org/10.1111/1469-0691.12037

• ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients

  Clinical Microbiology and Infection · 2012 · https://doi.org/10.1111/1469-0691.12039

• ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures

  Clinical Microbiology and Infection · 2012 · https://doi.org/10.1111/1469-0691.12038

• ESCMID guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)

  Clinical Microbiology and Infection · 2012 · https://doi.org/10.1111/1469-0691.12041

• Impact of Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry on the Clinical Management of Patients With Gram-negative Bacteremia: A Prospective Observational Study

  Clinical Infectious Diseases · 2012 · https://doi.org/10.1093/cid/cis1204

• Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

  Clinical Infectious Diseases · 2009 · https://doi.org/10.1086/596757

• Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria

  Clinical Infectious Diseases · 2008 · 10.1086/590566

• Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

  Clinical Infectious Diseases · 2008 · https://doi.org/10.1086/588660

• Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

  Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) · 2008 · https://doi.org/10.1097/01.ccm.0000298158.12101.41

• Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes

  Clinical Infectious Diseases · 2007 · 10.1086/524669

• Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008

  Intensive Care Medicine · 2007 · https://doi.org/10.1007/s00134-007-0934-2

• The International Sepsis Forum Consensus Conference on Definitions of Infection in the Intensive Care Unit

  Critical Care Medicine · 2005 · 10.1097/01.ccm.0000168253.91200.83

• Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock

  Intensive Care Medicine · 2004 · https://doi.org/10.1007/s00134-004-2210-z

• Epidemiology of Candidemia in Swiss Tertiary Care Hospitals: Secular Trends, 1991–2000

  Clinical Infectious Diseases · 2004 · 10.1086/380637

• Macrophage migration inhibitory factor: a regulator of innate immunity

  Nature reviews. Immunology · 2003 · 10.1038/nri1200

• 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer

  Clinical Infectious Diseases · 2002 · 10.1086/339215

• MIF regulates innate immune responses through modulation of Toll-like receptor 4

  Nature · 2001 · 10.1038/414920a

• Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1

  Nature · 2000 · 10.1038/35041591

• Protection from septic shock by neutralization of macrophage migration inhibitory factor

  Nature Medicine · 2000 · 10.1038/72262

• Oral versus Intravenous Empirical Antimicrobial Therapy for Fever in Patients with Granulocytopenia Who Are Receiving Cancer Chemotherapy

  New England Journal of Medicine · 1999 · https://doi.org/10.1056/nejm199907293410502

• An essential regulatory role for macrophage migration inhibitory factor in T-cell activation.

  Proceedings of the National Academy of Sciences · 1996 · 10.1073/pnas.93.15.7849

• Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program

  Antimicrobial Agents and Chemotherapy · 1996 · https://doi.org/10.1128/aac.40.5.1108

• MIF as a glucocorticoid-induced modulator of cytokine production

  Nature · 1995 · 10.1038/377068a0

• The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor.

  The Journal of Experimental Medicine · 1994 · 10.1084/jem.179.6.1895

• MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia

  Nature · 1993 · 10.1038/365756a0

• Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon- , and Interferon- in the Serum of Patients with Septic Shock

  The Journal of Infectious Diseases · 1990 · 10.1093/infdis/161.5.982

Current projects

No projects listed.